SlidesetHIVRSVCOVID-19Determinants of the Onset and Prognosis of the Post-COVID-19 Condition - R. Paredes, MD, PhD.pdfView Slideset
SlidesetHIVRSVCOVID-19Developing CAR T Cells for Use in Chronic HIV Infection - Martin Tolstrup, MSc, PhD.pdfView Slideset
SlidesetHIVRSVCOVID-19High Levels of Il-1, Tnf- and Mip-1 One Month after the Onset of the Acute SARS-CoV-2 Jacobo Alonso.pdfView Slideset
SlidesetHIVRSVCOVID-19HIV Exposed Uninfected (Heu) Infants Have Pro-inflammatory Bioprofiles That Correlate ... - Li Yin.pdfView Slideset
SlidesetHIVRSVCOVID-19Epstein–Barr Virus and Multiple Sclerosis Which Mechanisms are at Play - T. Lanz, MD.pdfView Slideset
SlidesetHIVRSVCOVID-19Immune Signatures in Vaccine-associated Myocarditis - A. Barmada, MPhil.pdfView Slideset
SlidesetHIVRSVCOVID-19Inflammasome Activation in Severe Cases of COVID-19 - Dario Zamboni, PhD.pdfView Slideset
SlidesetHIVRSVCOVID-19Possible Role of Intestinal Damage and Endotoxemia in the Development - L. Shostakovych-Koretskaya.pdfView Slideset
SlidesetHIVRSVCOVID-19The Plasma Microbiome Contributes to Immune Reconstitution in HIV Infected Individuals - Wei Jiang.pdfView Slideset
SlidesetHIVRSVCOVID-19Update on the REPRIEVE Trial to Prevent Cardiovascular Events in People with HIV - S. Grinspoon, MD.pdfView Slideset
SlidesetHIVRSVCOVID-19Update on the REPRIEVE Trial to Prevent Cardiovascular Events in PWH - Steven Grinspoon, MD.pdfView Slideset
